BR0015310A - Uso de agonistas do receptor de dopamina d3 - Google Patents

Uso de agonistas do receptor de dopamina d3

Info

Publication number
BR0015310A
BR0015310A BR0015310-9A BR0015310A BR0015310A BR 0015310 A BR0015310 A BR 0015310A BR 0015310 A BR0015310 A BR 0015310A BR 0015310 A BR0015310 A BR 0015310A
Authority
BR
Brazil
Prior art keywords
dopamine
receptor agonists
medicament
diagnosis
therapy
Prior art date
Application number
BR0015310-9A
Other languages
English (en)
Inventor
Bernd Muhlbauer
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of BR0015310A publication Critical patent/BR0015310A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"USO DE AGONISTAS DO RECEPTOR DE DOPAMINA D~ 3~". A invenção diz respeito ao uso de agonistas do receptor de dopamina D~ 3~ de modo a produzir um medicamento para o diagnóstico e terapia de hipertensão dependente de sal.
BR0015310-9A 1999-11-04 2000-10-31 Uso de agonistas do receptor de dopamina d3 BR0015310A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19953254 1999-11-04
PCT/EP2000/010770 WO2001032263A1 (de) 1999-11-04 2000-10-31 Verwendung von dopamin-d3-rezeptor-agonisten in der therapie der salzabhängigen hypertonie

Publications (1)

Publication Number Publication Date
BR0015310A true BR0015310A (pt) 2002-07-09

Family

ID=7928007

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015310-9A BR0015310A (pt) 1999-11-04 2000-10-31 Uso de agonistas do receptor de dopamina d3

Country Status (15)

Country Link
EP (1) EP1233815A1 (pt)
JP (1) JP2003513053A (pt)
KR (1) KR20020062300A (pt)
CN (1) CN1387450A (pt)
AU (1) AU1390801A (pt)
BR (1) BR0015310A (pt)
CA (1) CA2389643A1 (pt)
CZ (1) CZ20021521A3 (pt)
HU (1) HUP0203024A2 (pt)
IL (1) IL149266A0 (pt)
MX (1) MXPA02004103A (pt)
NO (1) NO20022142D0 (pt)
RU (1) RU2002114818A (pt)
WO (1) WO2001032263A1 (pt)
ZA (1) ZA200204455B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180599A1 (de) * 2000-08-16 2002-02-20 Siemens Building Technologies AG Sicherheitstechnische Einrichtung für eine Pumpe, die in einem Fluidgetriebe verwendet werden kann
JP2010184889A (ja) * 2009-02-12 2010-08-26 Nihon Univ 高血圧症予防治療薬
WO2011047350A2 (en) * 2009-10-16 2011-04-21 David Helton Emesis treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996030333A1 (en) * 1995-03-27 1996-10-03 Smithkline Beecham Plc Bicyclic amine derivatives and their use as anti-psychotic agents
FR2742149B1 (fr) * 1995-12-11 1998-02-13 Inst Nat Sante Rech Med Nouveaux derives de 2-naphtamides et leurs applications therapeutiques

Also Published As

Publication number Publication date
EP1233815A1 (de) 2002-08-28
ZA200204455B (en) 2003-09-04
AU1390801A (en) 2001-05-14
KR20020062300A (ko) 2002-07-25
CZ20021521A3 (cs) 2003-05-14
IL149266A0 (en) 2002-11-10
CN1387450A (zh) 2002-12-25
NO20022142L (no) 2002-05-03
JP2003513053A (ja) 2003-04-08
HUP0203024A2 (hu) 2003-02-28
MXPA02004103A (es) 2003-08-20
RU2002114818A (ru) 2004-01-10
CA2389643A1 (en) 2001-05-10
WO2001032263A1 (de) 2001-05-10
NO20022142D0 (no) 2002-05-03

Similar Documents

Publication Publication Date Title
BR0309544A (pt) Preparação farmacêutica contendo oxicodona e naloxona
BR0213358A (pt) Uso de flibanserina
BR0115847A (pt) Compostos especìficos para receptor para adenosina a1, a2a, e a3 e usos dos mesmos
AR020442A1 (es) Agonistas de 5ht2serotonergicos para el tratamiento de glaucoma
BR0006320A (pt) Cobertura de segurança de agulha
BR0107893A (pt) Agonistas e antagonistas de receptor de melanocortina
CL2008003941A1 (es) Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden compulsivo obsesivo.
BR0005011B1 (pt) mecanismo de soltura rápida para uso com respirador, testeira para uso com um respirador e respirador.
BR0114410A (pt) Associação de um antagonista de receptor cb1 e de sibutramina, as composições farmacêuticas que os contêm e a respectiva utilização para o tratamento da obesidade
NO20024309D0 (no) Intradermal penetreringsmidler for topikal lokal anestetisk administrering
ES2164040T1 (es) Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
RU2008143545A (ru) Применение антагониста рецептора ат-1 или модулятора рецептора ат-2 для лечения болезней, связанных с увеличением содержания рецепторов ат-1 или ат-2
BR0108471A (pt) Objeto pré-formado para liberar um agente ativo a um paciente, e, processos de formação de um objeto pré-formado para liberar um agente e de liberação de um agente ativo a um paciente
BR0107667A (pt) Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
HK1051324A1 (en) Methods and compositions for modulating alpha adrenergic receptor activity.
ES2190205T3 (es) Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda.
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
HUP9904109A2 (hu) Külsőleg használandó helyi érzéstelenítő
BR0015225A (pt) Tratamento de enfisema utilizando antagonistas retinóides seletivos para rar
ES2174337T3 (es) Uso topico de los agonistas opioides kappa para el tratamiento del dolor ocular.
BR0113165A (pt) Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados
BR0110450A (pt) Uso de agonistas receptores d4 de dopamina seletivo para tratamento de disfunção sexual
BR0015310A (pt) Uso de agonistas do receptor de dopamina d3
CL2002001701A1 (es) Uso de al menos un compuesto seleccionado entre melatonina, agentes melatoninergicos, agonistas y antagonistas de melatonina, en una cantidad de 0,0025-50 mg, para preparar un medicamento util para el tratamiento y mejora de la calidad repadora del sueno.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 45/00 (2006.01), A61P 9/12 (2006.01), A61K 31